IGHE and Alzheimer disease: Thus, even with IgE-specific IA, a thorough risk-benefit assessment is advised especially for patients in whom a peripheral venous access is not possible, considering that AD is strongly associated with increased susceptibility to skin infections by this bacterial pathogen.